This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolovan-Fritts, C. A.
Right arrow Articles by Spector, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolovan-Fritts, C. A.
Right arrow Articles by Spector, S. A.

 Previous Article  |  Next Article 

Journal of Virology, December 2004, p. 13173-13181, Vol. 78, No. 23
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.23.13173-13181.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Human Cytomegalovirus-Specific CD4+-T-Cell Cytokine Response Induces Fractalkine in Endothelial Cells

Cynthia A. Bolovan-Fritts,1 Rodney N. Trout,1 and Stephen A. Spector1,2,3*

Department of Pediatrics, Division of Infectious Diseases,1 Center for Molecular Genetics,2 Center for AIDS Research, University of California San Diego, La Jolla, California3

Received 28 May 2004/ Accepted 8 July 2004

Cytomegalovirus (CMV) infection has been linked to inflammation-related disease processes in the human host, including vascular diseases and chronic transplant rejection. The mechanisms through which CMV affects the pathogenesis of these diseases are for the most part unknown. To study the contributing role of the host immune response to CMV in these chronic inflammatory processes, we examined endothelial cell interactions with peripheral blood mononuclear cells (PBMC). Endothelial cultures were monitored for levels of fractalkine induction as a marker for initiating the host inflammatory response. Our results demonstrate that in the presence of CMV antigen PBMC from normal healthy CMV-seropositive donors produce soluble factors that induce fractalkine in endothelial cells. This was not observed in parallel assays with PBMC from seronegative donors. Examination of subset populations within the PBMC further revealed that CMV antigen-stimulated CD4+ T cells were the source of the factors, gamma interferon and tumor necrosis factor alpha, driving fractalkine induction. Direct contact between CD4+ cells and the endothelial monolayers is required for this fractalkine induction, where the endothelial cells appear to provide antigen presentation functions. These findings indicate that CMV may represent one member of a class of persistent pathogens where the antigen-specific T-cell response can result in the induction of fractalkine, leading to chronic inflammation and endothelial cell injury.


* Corresponding author. Mailing address: Department of Pediatrics, University of California at San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0672. Phone: (858) 534-7055. Fax: (858) 534-7411. E-mail: saspector{at}ucsd.edu.


Journal of Virology, December 2004, p. 13173-13181, Vol. 78, No. 23
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.23.13173-13181.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Walker, J. D., Maier, C. L., Pober, J. S. (2009). Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes. J. Immunol. 182: 1548-1559 [Abstract] [Full Text]  
  • Bolovan-Fritts, C. A., Spector, S. A. (2008). Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood 111: 175-182 [Abstract] [Full Text]  
  • Bolovan-Fritts, C. A., Trout, R. N., Spector, S. A. (2007). High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 110: 1857-1863 [Abstract] [Full Text]